Skip to main content
Log in

Neuropathological findings in 224 patients with temporal lobe epilepsy

  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

During the period between 1976 and 1990, 247 patients with pharmaco-resistant complex partial seizures and a documented unilateral epileptogenic area in the mediobasal temporal lobe underwent a selective amygdalo-hippocampectomy procedure at our institution. Biopsy specimens from 224 patients (91% of the total) were available for a retrospective histopathological and immunohistochemical review. The tissue specimens of 23 patients without evidence for a macroscopic lesion have been used for neurochemical studies and could not be evaluated histopathologically. The most common temporal lobe pathology were neoplasms in 126 patients, i.e. 56%. Tumor entities observed included 23 astrocytomas (18% of all tumors), 17 gangliogliomas (13%), 15 oligodendrogliomas (12%), 15 cases of glioblastoma multiforme (12%), 13 pilocytic astrocytomas (10%), 12 oligo-astrocytomas (10%), 11 anaplastic astrocytomas (9%) and 20 tumors of various other histologies. In 23 specimens (10%), small foci of oligodendroglia-like clear cells were found. The frequent association of these foci with low-grade gliomas or neural hamartomas raises the possibility that these structures may serve as precursor lesion for neuroepithelial tumors of the temporal lobe. In 98 cases, pathological changes of non-neoplastic origin were encountered. The most common diagnoses in this group included hippocampal gliosis/sclerosis (49 cases, 22%) and vascular malformations (20 cases, 9%). Hamartomas, i.e. focal accumulations of dysplastic neuro-glial cells were diagnosed in 14 patients (6%). In only four cases have we not been able to detect any microscopic pathology. These results indicate that a high proportion of pharmaco-therapy-resistent complex-partial seizures are caused by neoplasms of the temporal lobe, some of which appear to the strikingly overrepresented in this group of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Agosti R, Yasargil G, Egli M, Wieser HG, Wiestler OD (1990) Neuropathology of a human hippocampus following long term treatment with vigabatrin: lack of microvacuoles. Epilepsy Res 6:166–170

    Google Scholar 

  2. Armstrong DD, Bruton CJ (1987) Postscript: What terminology is appropriate for tissue pathology? How does it predict outcome? In: Engel Jr (ed) Surgical treatment of the epilepsies. Raven Press, New York, pp 541–552

    Google Scholar 

  3. Braak E, Olbrich HG, Braak H, Wieser HG, Oertel H (1986) Glutamic acid decarboxylase immunoreactivity in sector CA1 of the human Ammon's horn. Anat Embryol (Berl) 175:15–23

    Google Scholar 

  4. Bruton CJ (1988) The neuropathology of temporal lobe epilepsy. Maudsley Monographs No. 31. Oxford University Press, Oxford

    Google Scholar 

  5. Burger PC, Shibata T, Aguzzi A, Kleihues P (1988) Selective induction by N-Nitrosoethylurea of oligodendrogliomas in fetal forebrain transplants. Cancer Res 48:2871–2875

    Google Scholar 

  6. Chan-Palay V, Kohler C, Haesler V, Lang W, Yasargil G (1986) Distribution of neurons and axons immunoreactive with antisera against neuropeptide Y in the normal human hippocampus. J Comp Neurol 248:360–375

    Google Scholar 

  7. Daumas-Duport C, Scheithauer BW, Chodkiewicz J-P, Laws ER, Vedrenne C (1988) Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 23:545–556

    Google Scholar 

  8. Duncan JS, Sagar HJ (1987) Seizure characteristics, pathology, and outcome after temporal lobectomy. Neurology 37:405–409

    Google Scholar 

  9. Estes ML, Morris III HH, Lüders H, Dudley AW Jr, Lesser RP, Dinner DS, Friedman D, Hahn JF, Wyllie E (1988) Surgery for intractable epilepsy. Cleve Clin J Med 55:441–447

    Google Scholar 

  10. Falconer MA, Serafetinides EA, Corsellis JAN, Cavanagh JB (1964) Etiology and pathogenesis of temporal lobe epilepsy. Arch Neurol 10:233–248

    Google Scholar 

  11. Mathieson G (1975) Pathology of temporal lobe epilepsy. Adv Neurol 11:163–185

    Google Scholar 

  12. McMillan TM, Powell GE, Janota I, Polkey CE (1987) Relationships between neuropathology and cognitive functioning in temporal lobectomy specimens. J Neurol Neurosurg Psychiatry 50:167–176

    Google Scholar 

  13. Penfield W, Jasper H (1954) Epilepsy and the functional anatomy of the human brain. Little Brown, Boston

    Google Scholar 

  14. Rasmussen TB (1983) Surgical treatment of complex partial seizures: Results, lessons, and problems. Epilepsia 24 [Suppl 1]:65–76

    Google Scholar 

  15. Roberts GW, Crow TJ, Polak JM (1982) Immunocytochemical localization of neuropeptides in the human hippocampus. J Histochem Cytochem 30:577

    Google Scholar 

  16. Scheuer ML, Pedley TA (1990) Current concepts: the evaluation and treatment of seizures. N Engl J Med 323:1468–1474

    Google Scholar 

  17. Wieser HG (1988) Selective amygdalo-hippocampectomy for temporal lobe epilepsy. Epilepsia 29 [Suppl 2]: 100–113

    Google Scholar 

  18. Wieser HG (1991) Comparison of valproate concentrations in human plasma, CSF, and brain tissue after administration of different formulations of valproate or valpromide. Epilepsy Res 9:154–159

    Google Scholar 

  19. Wieser HG (1986) Selective amygdalohippocamptectomy: indications, investigative technique and results. Adv Tech Stand Neurosurg 13:39–133

    Google Scholar 

  20. Wieser HG, Moser S (1988) Improved multipolar foramen ovale electrode monitoring. J Epilepsy 1:13–22

    Google Scholar 

  21. Wieser HG, Siegel AM (1991) Nachunterschungen bei Patienten mit selektiver Amygdala-Hippocamptektomic. Epilepsie Blätter 4:3–7

    Google Scholar 

  22. Wieser HG, Yasargil MG (1982) Selective amygdalohippocampectomy as a surgical treatment of mesiobasal limbic epilepsy. Surg Neurol 17:445–457

    Google Scholar 

  23. Wieser HG, Stodiek SRG, Elger CE (1986) Chronic and acute add-on administration of flunarizine in patients with drug-resistant partial seizures: effect on seizures, surface and depth EEG, and cognitive performance. In: Speckmann E-J, Schulze H, Walden I (eds) Epilepsy and calcium. Urban & Schwarzenberg, München, pp 417–445

    Google Scholar 

  24. Wieser HG, Siegel AM, Yasargil GM (1990) The Zürich amygdalo-hippocampectomy series: a short up-date. Acta Neurochir (Wien) 50 [Suppl]: 122–127

    Google Scholar 

  25. Wieser HG, Engel J Jr, Babb TL, Gloor P (1993) Surgically remidiable temporal lobe syndromes. In: Engel J Jr (ed) Surgical treatment of the epilepsies, 2nd edn. Raven Press, New York, pp 49–63

    Google Scholar 

  26. Wolf HK, Zentner J, Hufnagel A, Schramm J, Elger CE, Wiestler OD (1993) Surgical pathology of temporal lobe epilepsy: experience with 216 cases. J Neuropathol Exp Neurol (in press)

  27. Yasargil MG, Teddy PJ, Roth P (1985) Selective amygdalohippocampectomy: operative anatomy and surgical technique. Adv Tech Stand Neurosurg 12:93–123

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Plate, K.H., Wieser, HG., Yasargil, M.G. et al. Neuropathological findings in 224 patients with temporal lobe epilepsy. Acta Neuropathol 86, 433–438 (1993). https://doi.org/10.1007/BF00228577

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00228577

Key words

Navigation